KMS KUNMING INSTITUTE OF ZOOLOGY.CAS
| Selective loss of 5hmC promotes neurodegeneration in the mouse model of Alzheimer's disease | |
Zhang, Y ; Zhang, ZY; Li, LW; Xu, KY; Ma, ZS; Chow, HM; Herrup, K; Li, JL
| |
| 2020 | |
| 发表期刊 | FASEB JOURNAL
![]() |
| ISSN | 0892-6638 |
| 卷号 | 34期号:12页码:16364-16382 |
| 摘要 | 5-hydroxymethylcytosine (5hmC) is an intermediate stage of DNA de-methylation. Its location in the genome also serves as an important regulatory signal for many biological processes and its levels change significantly with the etiology of Alzheimer's disease (AD). In keeping with this relationship, the TET family of enzymes which convert 5-methylcytosine (5mC) to 5hmC are responsive to the presence of A beta. Using hMeDIP-seq, we show that there is a genome-wide reduction of 5hmC that is found in neurons but not in astrocytes from 3xTg mice (an AD mouse model). Decreased TET enzymatic activities in the brains of persons who died with AD suggest that this reduction is the main cause for the loss of 5hmC. Overexpression of human TET catalytic domains (hTETCDs) from the TET family members, especially for hTET3CD, significantly attenuates the neurodegenerative process, including reduced A beta accumulation as well as tau hyperphosphorylation, and improve synaptic dysfunction in 3xTg mouse brain. Our findings define a crucial role of deregulated 5hmC epigenetics in the events leading to AD neurodegeneration. |
| 收录类别 | sci |
| 语种 | 英语 |
| 文献类型 | 期刊论文 |
| 条目标识符 | http://ir.kiz.ac.cn/handle/152453/13316 |
| 专题 | 科研部门_表观遗传与神经退行性疾病(李家立) |
| 推荐引用方式 GB/T 7714 | Zhang, Y,Zhang, ZY,Li, LW,et al. Selective loss of 5hmC promotes neurodegeneration in the mouse model of Alzheimer's disease[J]. FASEB JOURNAL,2020,34(12):16364-16382. |
| APA | Zhang, Y.,Zhang, ZY.,Li, LW.,Xu, KY.,Ma, ZS.,...&Li, JL.(2020).Selective loss of 5hmC promotes neurodegeneration in the mouse model of Alzheimer's disease.FASEB JOURNAL,34(12),16364-16382. |
| MLA | Zhang, Y,et al."Selective loss of 5hmC promotes neurodegeneration in the mouse model of Alzheimer's disease".FASEB JOURNAL 34.12(2020):16364-16382. |
| 条目包含的文件 | ||||||
| 文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
| 2023040603.pdf(2354KB) | 期刊论文 | 出版稿 | 开放获取 | CC BY-NC-SA | 请求全文 | |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论